Coverage for medications is determined by the Drug List and is subject to the member's specific benefit rules and any special requirements shown on the formulary. In general, coverage applies to drugs that are listed on the BCBSNM Drug List and that meet plan rules; many entries include administrative controls such as Prior Authorization (PA), Quantity Limits (QL) and Specialty Pharmacy (SP) routing which must be satisfied for coverage to be approved. Typical dispensing expectations are a 30‑day supply for most prescriptions and up to a 90‑day supply for maintenance medications where the benefit allows. [[chunk 9]]
The Drug List presents per‑product formulary placement (Drug Tier) and line‑level requirements. When an item is marked with PA the prescriber must submit a prior authorization request and obtain approval before the payer will cover the medication. Entries that include QL specify the maximum permitted quantity and time window (for example, many antiretrovirals and DAAs show QL (30 tablets/30 days)). Products marked SP must be dispensed through specialty pharmacy channels as indicated. Coverage is therefore conditional on meeting those per‑product requirements. [[chunk 36]][[chunk 37]][[chunk 72]]
Examples from the listing illustrate how utilization management is applied at the product level. Selected antiviral and anti‑infective products show QL limits (e.g., BIKTARVY QL (30 tablets/30 days); linezolid suspension QL (600 mL/180 days)). Many oncology and specialty agents are designated PA, QL, SP (for example, Zytiga/abiraterone PA, QL (60 tablets/30 days), SP; alectinib PA, QL (240 capsules/30 days), SP). Biologic and specialty injectables (e.g., benralizumab, mepolizumab) are shown with PA and product‑specific QLs and are managed via specialty pharmacy where indicated. Providers should follow the line‑item Requirements/Limits for each product. [[chunk 54]][[chunk 72]][[chunk 216]]
The Drug List also identifies items that are not covered under typical pharmacy benefits: repackaged medications, non–FDA‑approved drugs, certain compounded medications and some prescription products that have available over‑the‑counter equivalents may be excluded from coverage. Where an entry shows administrative flags only (PA/QL/SP) the document excerpt does not provide full clinical medical‑necessity criteria — those are managed through the payer's PA processes and documentation requirements. Providers should consult plan materials or the PA process to determine the specific clinical documentation required for approval. [[chunk 9]][[chunk 72]][[chunk 108]]